Cargando…

Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure

AIM: The role of serum type III procollagen peptide (P3P) level in the acute phase of acute heart failure (AHF) requires clarification. We hypothesized that serum P3P level is temporarily higher during the acute phase, reflecting liver dysfunction due to congestion. METHODS AND RESULTS: A total of 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirakabe, Akihiro, Okazaki, Hirotake, Matsushita, Masato, Shibata, Yusaku, Shigihara, Shota, Nishigoori, Suguru, Sawatani, Tomofumi, Sasamoto, Nozomi, Kiuchi, Kazutaka, Atsukawa, Masanori, Itokawa, Norio, Arai, Taeang, Kobayashi, Nobuaki, Asai, Kuniya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065836/
https://www.ncbi.nlm.nih.gov/pubmed/35289118
http://dx.doi.org/10.1002/ehf2.13878
_version_ 1784699675682537472
author Shirakabe, Akihiro
Okazaki, Hirotake
Matsushita, Masato
Shibata, Yusaku
Shigihara, Shota
Nishigoori, Suguru
Sawatani, Tomofumi
Sasamoto, Nozomi
Kiuchi, Kazutaka
Atsukawa, Masanori
Itokawa, Norio
Arai, Taeang
Kobayashi, Nobuaki
Asai, Kuniya
author_facet Shirakabe, Akihiro
Okazaki, Hirotake
Matsushita, Masato
Shibata, Yusaku
Shigihara, Shota
Nishigoori, Suguru
Sawatani, Tomofumi
Sasamoto, Nozomi
Kiuchi, Kazutaka
Atsukawa, Masanori
Itokawa, Norio
Arai, Taeang
Kobayashi, Nobuaki
Asai, Kuniya
author_sort Shirakabe, Akihiro
collection PubMed
description AIM: The role of serum type III procollagen peptide (P3P) level in the acute phase of acute heart failure (AHF) requires clarification. We hypothesized that serum P3P level is temporarily higher during the acute phase, reflecting liver dysfunction due to congestion. METHODS AND RESULTS: A total of 800 AHF patients were screened, and data from 643 patients were analysed. Heart failure was diagnosed by the treating physician according to the European Society of Cardiology (ESC) guidelines, and included patients being treated with high‐concentration oxygen inhalation (including mechanical support) for orthopnea, inotrope administration, or mechanical support for low blood pressure, and various types of diuretics for peripheral or pulmonary oedema. In all cases, diuretics or vasodilators were administered to treat AHF. The patients were divided into three groups according to their quartile (Q) serum P3P level: low‐P3P (Q1, P3P ≤ 0.6 U/mL), mid‐P3P (Q2/Q3, 0.6 < P3P <1.2 U/mL), and high‐P3P (Q4, P3P ≥ 1.2 U/mL). The plasma volume status (PVS) was calculated using the following formula: ([actual PV − ideal PV]/ideal PV) × 100 (%). The primary endpoint was 365 day mortality. A Kaplan–Meier curve analysis showed that prognoses, including all‐cause mortality and heart failure events within 365 days, were significantly (P < 0.001) worse in the high‐P3P group when compared with the mid‐P3P and low‐P3P groups. A multivariate logistic regression analysis showed that high PVS (Q4, odds ratio [OR]: 4.702, 95% CI: 2.012–20.989, P < 0.001), high fibrosis‐4 index (Q4, OR: 2.627, 95% CI: 1.311–5.261, P = 0.006), and low estimated glomerular filtration rate per 10 mL/min/1.73 m(2) decrease (OR: 1.996, 95% CI: 1.718–2.326, P < 0.001) were associated with high P3P values. The Kaplan–Meier curve analysis demonstrated a significantly lower survival rate, as well as a higher rate of heart failure events, in the high‐P3P and high‐PVS groups when compared with the other groups. A multivariate Cox regression model identified high P3P level and high PVS as an independent predictor of 365 day all‐cause mortality (hazard ratio [HR]: 2.249; 95% CI: 1.081–3.356; P = 0.026) and heart failure events (HR: 1.586, 95% CI: 1.005–2.503, P = 0.048). CONCLUSION: A high P3P level during the acute phase of AHF served as a comprehensive biomarker of liver dysfunction with volume overload (i.e. liver congestion) and renal dysfunction. A high P3P level at admission may be able to predict adverse outcomes in AHF patients.
format Online
Article
Text
id pubmed-9065836
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90658362022-05-04 Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure Shirakabe, Akihiro Okazaki, Hirotake Matsushita, Masato Shibata, Yusaku Shigihara, Shota Nishigoori, Suguru Sawatani, Tomofumi Sasamoto, Nozomi Kiuchi, Kazutaka Atsukawa, Masanori Itokawa, Norio Arai, Taeang Kobayashi, Nobuaki Asai, Kuniya ESC Heart Fail Original Articles AIM: The role of serum type III procollagen peptide (P3P) level in the acute phase of acute heart failure (AHF) requires clarification. We hypothesized that serum P3P level is temporarily higher during the acute phase, reflecting liver dysfunction due to congestion. METHODS AND RESULTS: A total of 800 AHF patients were screened, and data from 643 patients were analysed. Heart failure was diagnosed by the treating physician according to the European Society of Cardiology (ESC) guidelines, and included patients being treated with high‐concentration oxygen inhalation (including mechanical support) for orthopnea, inotrope administration, or mechanical support for low blood pressure, and various types of diuretics for peripheral or pulmonary oedema. In all cases, diuretics or vasodilators were administered to treat AHF. The patients were divided into three groups according to their quartile (Q) serum P3P level: low‐P3P (Q1, P3P ≤ 0.6 U/mL), mid‐P3P (Q2/Q3, 0.6 < P3P <1.2 U/mL), and high‐P3P (Q4, P3P ≥ 1.2 U/mL). The plasma volume status (PVS) was calculated using the following formula: ([actual PV − ideal PV]/ideal PV) × 100 (%). The primary endpoint was 365 day mortality. A Kaplan–Meier curve analysis showed that prognoses, including all‐cause mortality and heart failure events within 365 days, were significantly (P < 0.001) worse in the high‐P3P group when compared with the mid‐P3P and low‐P3P groups. A multivariate logistic regression analysis showed that high PVS (Q4, odds ratio [OR]: 4.702, 95% CI: 2.012–20.989, P < 0.001), high fibrosis‐4 index (Q4, OR: 2.627, 95% CI: 1.311–5.261, P = 0.006), and low estimated glomerular filtration rate per 10 mL/min/1.73 m(2) decrease (OR: 1.996, 95% CI: 1.718–2.326, P < 0.001) were associated with high P3P values. The Kaplan–Meier curve analysis demonstrated a significantly lower survival rate, as well as a higher rate of heart failure events, in the high‐P3P and high‐PVS groups when compared with the other groups. A multivariate Cox regression model identified high P3P level and high PVS as an independent predictor of 365 day all‐cause mortality (hazard ratio [HR]: 2.249; 95% CI: 1.081–3.356; P = 0.026) and heart failure events (HR: 1.586, 95% CI: 1.005–2.503, P = 0.048). CONCLUSION: A high P3P level during the acute phase of AHF served as a comprehensive biomarker of liver dysfunction with volume overload (i.e. liver congestion) and renal dysfunction. A high P3P level at admission may be able to predict adverse outcomes in AHF patients. John Wiley and Sons Inc. 2022-03-14 /pmc/articles/PMC9065836/ /pubmed/35289118 http://dx.doi.org/10.1002/ehf2.13878 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Shirakabe, Akihiro
Okazaki, Hirotake
Matsushita, Masato
Shibata, Yusaku
Shigihara, Shota
Nishigoori, Suguru
Sawatani, Tomofumi
Sasamoto, Nozomi
Kiuchi, Kazutaka
Atsukawa, Masanori
Itokawa, Norio
Arai, Taeang
Kobayashi, Nobuaki
Asai, Kuniya
Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
title Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
title_full Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
title_fullStr Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
title_full_unstemmed Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
title_short Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
title_sort type iii procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065836/
https://www.ncbi.nlm.nih.gov/pubmed/35289118
http://dx.doi.org/10.1002/ehf2.13878
work_keys_str_mv AT shirakabeakihiro typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT okazakihirotake typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT matsushitamasato typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT shibatayusaku typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT shigiharashota typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT nishigoorisuguru typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT sawatanitomofumi typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT sasamotonozomi typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT kiuchikazutaka typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT atsukawamasanori typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT itokawanorio typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT araitaeang typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT kobayashinobuaki typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure
AT asaikuniya typeiiiprocollagenpeptidelevelcanindicateliverdysfunctionassociatedwithvolumeoverloadinacuteheartfailure